Joseph Lipscomb

Summary

Affiliation: Emory University
Country: USA

Publications

  1. pmc Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Breast Cancer Res Treat 133:285-96. 2012
  2. ncbi request reprint Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
  3. doi request reprint State-level cancer quality assessment and research: building and sustaining the data infrastructure
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    Cancer J 17:246-56. 2011
  4. ncbi request reprint Cancer outcomes measurement: Through the lens of the Medical Outcomes Trust framework
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Rm 642, 1518 Clifton Road, NE, Atlanta, GA 30322, USA
    Qual Life Res 16:143-64. 2007
  5. pmc Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base
    Lauren E Colbert
    Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia
    Cancer 120:499-506. 2014
  6. doi request reprint Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base
    Rachel L Medbery
    Section of General Thoracic Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    J Thorac Oncol 11:222-33. 2016
  7. doi request reprint Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis
    Ronica H Nanda
    Department of Radiation Oncology, Emory University, Atlanta, Georgia
    Cancer 121:4222-30. 2015
  8. doi request reprint Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost
    Daniel A Goldstein
    Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia
    JAMA Oncol 1:1293-300. 2015
  9. doi request reprint Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer
    Daniel A Goldstein
    Daniel A Goldstein, Bilal B Ahmad, David H Howard, Joseph Lipscomb, Bassel F El Rayes, and Christopher R Flowers, Emory University and Qiushi Chen and Turgay Ayer, Georgia Institute of Technology, Atlanta, GA
    J Clin Oncol 33:3727-32. 2015
  10. pmc Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base
    John N Melvan
    Department of Surgery, Emory University School of Medicine, Atlanta, GA
    J Am Coll Surg 221:550-63. 2015

Detail Information

Publications38

  1. pmc Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Breast Cancer Res Treat 133:285-96. 2012
    ..Further investigation is warranted, both in SWGA and in other rural regions...
  2. ncbi request reprint Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
    ....
  3. doi request reprint State-level cancer quality assessment and research: building and sustaining the data infrastructure
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    Cancer J 17:246-56. 2011
    ..The pace of progress depends on the successful resolution of issues related to the application of information technology, financing, and governance...
  4. ncbi request reprint Cancer outcomes measurement: Through the lens of the Medical Outcomes Trust framework
    Joseph Lipscomb
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, Rm 642, 1518 Clifton Road, NE, Atlanta, GA 30322, USA
    Qual Life Res 16:143-64. 2007
    ..To guide its work, the COMWG adopted the revised Medical Outcomes Trust (MOT) attributes and review criteria for evaluating health status and quality-of-life instruments...
  5. pmc Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base
    Lauren E Colbert
    Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia
    Cancer 120:499-506. 2014
    ..The authors used the National Cancer Data Base (NCDB) to report prRT outcomes for the largest multi-institutional patient cohort to date...
  6. doi request reprint Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base
    Rachel L Medbery
    Section of General Thoracic Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    J Thorac Oncol 11:222-33. 2016
    ..Potential differences in nodal staging based on operative approach remain the final significant barrier to widespread adoption of VATS lobectomy. The current study examines differences in nodal staging between open and VATS lobectomy...
  7. doi request reprint Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis
    Ronica H Nanda
    Department of Radiation Oncology, Emory University, Atlanta, Georgia
    Cancer 121:4222-30. 2015
    ..An analysis of the National Cancer Data Base (NCDB) was undertaken to determine whether definitive SBRT improves survival relative to observation alone patients ages 70 years and older...
  8. doi request reprint Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost
    Daniel A Goldstein
    Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia
    JAMA Oncol 1:1293-300. 2015
    ..84). However, the costs and value associated with this intervention remains unclear. Value-based pricing links the price of a drug to the benefit that it provides and is a novel method to establish prices for new treatments...
  9. doi request reprint Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer
    Daniel A Goldstein
    Daniel A Goldstein, Bilal B Ahmad, David H Howard, Joseph Lipscomb, Bassel F El Rayes, and Christopher R Flowers, Emory University and Qiushi Chen and Turgay Ayer, Georgia Institute of Technology, Atlanta, GA
    J Clin Oncol 33:3727-32. 2015
    ..Given this small incremental clinical benefit, we evaluated the cost-effectiveness of regorafenib in the third-line setting for patients with metastatic colorectal cancer from the US payer perspective...
  10. pmc Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base
    John N Melvan
    Department of Surgery, Emory University School of Medicine, Atlanta, GA
    J Am Coll Surg 221:550-63. 2015
    ....
  11. ncbi request reprint Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer
    Ruben G W Quek
    From the Department of Health Policy and Management, Department of Epidemiology, Winship Cancer Institute, and Department of Urology, Emory University Surveillance and Health Services Research Program, and Statistics and Evaluation Center, Intramural Research Department, American Cancer Society and Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia
    J Natl Compr Canc Netw 13:303-9. 2015
    ..The NCCN Guidelines for Prostate Cancer recommend radiation as a therapy option for patients with locoregional prostate cancer...
  12. doi request reprint First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis
    Daniel A Goldstein
    Daniel A Goldstein, David H Howard, Joseph Lipscomb, Bassel F El Rayes, and Christopher R Flowers, Emory University and Qiushi Chen and Turgay Ayer, Georgia Institute of Technology, Atlanta, GA
    J Clin Oncol 33:1112-8. 2015
    ..Our objective was to determine the cost effectiveness of bevacizumab in the first-line setting and when continued beyond progression from the perspective of US payers...
  13. doi request reprint Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer
    Ruben G W Quek
    Statistics and Evaluation Center, Intramural Research Department, American Cancer Society and Department of Health Policy and Management, Emory University, Atlanta, Georgia Electronic address
    Urol Oncol 32:748-60. 2014
    ....
  14. doi request reprint Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base
    David A Kooby
    Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA
    Ann Surg Oncol 20:3634-42. 2013
    ..The impact of adjuvant radiotherapy for pancreatic adenocarcinoma (PAC) remains controversial. We examined effects of adjuvant therapy on overall survival (OS) in PAC, using the National Cancer Data Base (NCDB)...
  15. doi request reprint Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base
    Onkar V Khullar
    Division of Cardiothoracic Surgery, Biostatistics and Bioinformatics Shared Resource at Winship Cancer Institute, Rollins School of Public Health, Department of Hematology and Medical Oncology, Department of Surgery, Department of Radiation Oncology, and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia
    J Thorac Oncol 10:1625-33. 2015
    ..Our aim was to evaluate and compare short-term and long-term survival for these surgical approaches...
  16. pmc Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base
    John L Mikell
    Departments of Radiation Oncology, Hematology and Oncology, Surgery, Biostatistics and Bioinformatics Shared Resource, Rollins School of Public Health, and the Winship Cancer Institute, Emory University, Atlanta, GA
    J Thorac Oncol 10:462-71. 2015
    ..Limited data indicate that PORT may benefit patients with involved N2 nodes. This study evaluates this hypothesis in a large retrospective cohort treated with chemotherapy and contemporary radiation techniques...
  17. doi request reprint Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer
    Ruben G W Quek
    Statistics and Evaluation Center, Intramural Research Department, American Cancer Society and Department of Health Policy and Management, Emory University, Atlanta, Georgia
    Cancer 119:3619-28. 2013
    ....
  18. ncbi request reprint Patient-reported outcomes in cancer: a review of recent research and policy initiatives
    Joseph Lipscomb
    Rollins School of Publci Health, Emory Universoity, Atlanta, GA, USA
    CA Cancer J Clin 57:278-300. 2007
    ....
  19. doi request reprint The value of new chemotherapeutic agents for metastatic colorectal cancer
    David H Howard
    Department of Health Policy and Management, Emory University, Atlanta, GA 30030, USA
    Arch Intern Med 170:537-42. 2010
    ..We measure trends in life expectancy and lifetime medical costs in this patient population between January 1, 1995, and December 31, 2005...
  20. doi request reprint Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area
    Xinwei Hua
    Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd, NE, Atlanta, GA, 30322, USA
    J Community Health 39:696-705. 2014
    ..The results from SWGA stand in contrast to studies that applied different methodologies and were conducted elsewhere...
  21. pmc Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base
    Onkar V Khullar
    Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA
    J Am Coll Surg 220:156-168.e4. 2015
    ..Our aim was to examine the impact of other clinical and demographic variables, controlling for known predictors of long-term survival, in order to investigate how outcomes varied according to important nonclinical factors...
  22. doi request reprint Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer
    Daniel A Goldstein
    Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA Electronic address
    Clin Colorectal Cancer 13:219-25. 2014
    ..The objective of this study was to compare the cost effectiveness of PK-based 5-FU dosing with BSA-based 5-FU dosing in patients with mCRC receiving FOLFOX (5-FU, leucovorin, and oxaliplatin)...
  23. doi request reprint Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation
    David H Howard
    Department of Health Policy and Management, Emory University, Atlanta, Georgia, USA
    Health Aff (Millwood) 32:596-602. 2013
    ..Although 42 percent of men in this age group continue to receive PSA tests, our results highlight the potential of guidelines with negative recommendations to reduce the use of low-value medical care...
  24. pmc The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma
    William A Hall
    Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA
    Cancer 119:2350-7. 2013
    ..Adjuvant radiotherapy (A-RT) for patients with resected pancreatic adenocarcinoma (PAC) is controversial. In the current study, the authors aim to determine whether there is an association between overall survival (OS) and A-RT dose...
  25. pmc Examining racial differences in diffuse large B-cell lymphoma presentation and survival
    Christopher R Flowers
    Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    Leuk Lymphoma 54:268-76. 2013
    ..61, p = 0.01). Future studies should examine biological differences that may underlie the observed racial differences in presentation and outcome...
  26. pmc Cancer outcomes research in a rural area: a multi-institution partnership model
    Michael Goodman
    Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA 30322, USA
    J Community Health 34:23-32. 2009
    ..Our partnership model may provide a useful framework for cancer outcomes research projects in rural communities...
  27. pmc Screening adults for pre-diabetes and diabetes may be cost-saving
    Ranee Chatterjee
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    Diabetes Care 33:1484-90. 2010
    ..Early detection would allow management to prevent or delay development of diabetes and diabetes-related complications. We investigated the economic justification for screening for pre-diabetes/diabetes...
  28. ncbi request reprint Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making
    Steven B Clauser
    National Cancer Institute, Bethesda, MD, USA
    J Clin Oncol 25:5049-50. 2007
  29. ncbi request reprint Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase
    Carolyn C Gotay
    Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813, USA
    J Natl Cancer Inst 97:1568-74. 2005
    ..Research is needed to develop and test predictive models of HRQOL and to establish the added value of including HRQOL assessment in clinical trials...
  30. ncbi request reprint Quality of life in patients with Barrett's esophagus undergoing surveillance
    Deborah Fisher
    Durham Veterans Affairs Medical Center, Institute for Clinical and Epidemiological Research, North Carolina, USA
    Am J Gastroenterol 97:2193-200. 2002
    ....
  31. ncbi request reprint Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium
    John Z Ayanian
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 22:2992-6. 2004
  32. ncbi request reprint Managed care market penetration, spillover effects, and the quality of cancer care
    Joseph Lipscomb
    J Natl Cancer Inst 97:242-4. 2005
  33. ncbi request reprint Outcomes research at the National Cancer Institute: measuring, understanding, and improving the outcomes of cancer care
    Joseph Lipscomb
    Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Clin Ther 25:699-712. 2003
    ....
  34. ncbi request reprint Next steps for use of item response theory in the assessment of health outcomes
    Ron D Hays
    David Geffen School of Medicine, UCLA RAND Health Program, Santa Monica, CA 90407, USA
    Qual Life Res 16:195-9. 2007
    ..We review the NCI/DIA conference, "Improving health outcomes assessment based on modern measurement theory and computerized adaptive testing," and suggest next steps in use of item response theory (IRT) to assess health outcomes...
  35. ncbi request reprint Measuring outcomes in randomized prospective trials in palliative care
    Richard A Mularski
    Kaiser Permanente Center for Health Research, Oregon Health and Science University, Portland, OR 97227, USA
    J Pain Symptom Manage 34:S7-S19. 2007
    ..As other fields have developed and refined methodological approaches that address their particular research needs, palliative care researchers must do the same to answer important clinical questions in rigorous and credible ways...
  36. ncbi request reprint Patient-reported outcomes: conceptual issues
    Margaret L Rothman
    Johnson and Johnson Pharmaceutical Services LLC, Raritan, NJ, USA
    Value Health 10:S66-75. 2007
    ....
  37. doi request reprint Estimating the cost of cancer care in the United States: a work very much in progress
    Joseph Lipscomb
    J Natl Cancer Inst 100:607-10. 2008
  38. ncbi request reprint The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative
    Joseph Lipscomb
    Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 40:III3-10. 2002
    ..The agency has concluded that outcomes research to date has made substantial contributions at level 1, but has had little impact at levels 2 to 4...